Observing recovery from weakness after severe respiratory and cardiac failure

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational pilot study aims to identify the factors influencing recovery from intensive care unit-acquired weakness (ICUAW) in patients who have experienced severe cardiorespiratory failure and required extra-corporeal membrane oxygenation (ECMO). The study will assess the impact of ICUAW on physical function and health-related quality of life (HRQoL) following critical illness. By examining real-life cases, the research seeks to uncover the determinants of recovery and the associated risks of ICUAW, which can significantly affect patient outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Above the age of 18
* Adults with severe cardio-respiratory failure requiring ECMO.
* Adults who have had personal and professional consultees agree to enrol them in the trial.

Exclusion criteria:

* Previous Stroke
* Neuromuscular disease
* Malignancy
* Underlying neuromuscular disease
* paediatrics

Where it's running

• St Bartholomew's hospital (Barts NHS trust)
  London, United Kingdom Recruiting

Study contacts

• Principal investigator: Mark Griffiths, PhD FRCP — Substantive Employee and primary supervisor to PhD student
• Study coordinator: Mark Griffiths, PhD FRCP
• Email: Mark.griffiths@bartshealth.nhs.uk
• Phone: 07875999126

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Platelet population changes during ECMO circulatory support

  This will test whether the proportions of different platelet types change during ECMO in adults with cardiac or respiratory failure.

  Recruiting University Hospital, Strasbourg, France · Strasbourg · NCT07334457

• Effect of phosphocreatine on patients treated by medical emergency teams

  This study tests if giving phosphocreatine to hospitalized patients with serious conditions can help them recover faster and shorten their hospital stays compared to those who receive a placebo.

  Recruiting Phase 3 Università Vita-Salute San Raffaele · Milan · NCT06503016

• Comparing precision ventilation to standard care for ARDS

  This study tests if a personalized breathing method can help people with Acute Respiratory Distress Syndrome survive better than the usual care they receive.

  Recruiting at 30 sites Phase 3 Beth Israel Deaconess Medical Center · Tucson, Arizona and 32 other locations · NCT06066502

• How diaphragm strength changes during and after mechanical ventilation

  This project will try to see how quickly the diaphragm weakens in ICU patients on mechanical ventilation and whether it recovers after they are taken off the ventilator.

  Recruiting RWTH Aachen University · Aachen · NCT05211661

• Evaluating the safety and performance of the MOBYBOX System for heart and lung support

  This study is testing how safe and effective the MOBYBOX system is for helping patients with heart and lung failure.

  Recruiting at 4 sites Hemovent GmbH · Hanover, Lower Saxony and 3 other locations · NCT04183660

• Study on muscle weakness after surgery in intensive care patients

  This study is testing if changes in blood and muscle samples from surgical patients can help us understand and find markers for muscle weakness that happens after being in intensive care.

  Recruiting Technical University of Munich · Vienna, State of Vienna and 2 other locations · NCT03810768

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.